Dominari Holdings Inc (DOMH)
Notification from Dominari Holdings Inc
Heart Test Laboratories Inc (HSCSW)
HeartSciences Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update
Cellectis (CLLS)
Cellectis Announces Arbitral Decision in Dispute with Servier
Becton Dickinson and Company (BDX)
BD Expands BD MAX™ System Menu with New IVDR-Certified VIASURE Assays in Partnership with Certest Biotec
Arrowhead Pharmaceuticals Inc (ARWR)
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
AstraZeneca (AZN)
ENHERTU® (fam-trastuzumab deruxtecan-nxki) plus pertuzumab approved in the US as first new treatment in a decade for the 1st-line treatment of patients with HER2-positive metastatic breast cancer
Johnson & Johnson (JNJ)
Johnson & Johnson - Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results
Johnson & Johnson (JNJ)
Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results
Organogenesis Holdings Inc. (ORGO)
Organogenesis Announces Successful FDA Meeting and Plan to File BLA for ReNu® for Knee Osteoarthritis Pain
Shattuck Labs Inc (STTK)
Shattuck Labs - Shattuck Labs, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)